Caribou Biosciences, Inc.

Healthcare

NASDAQ:CRBU · NASDAQ Global Select

Market Cap $161.17M Beta 2.33 P/E (TTM) -1.1

$1.64 -2.74%

-$0.05 today

52W Low $1.20High $3.54

Vol 2.52M · Avg 1.83M

EPS (TTM) -$1.39Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+24.24%

Period High

$2.84

Period Low

$1.25

Latest

$1.64

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Allogene Therapeutics, Inc.

NASDAQ:ALLO

$492.62M

Prelude Therapeutics Incorporated

NASDAQ:PRLD

$331.26M

Enanta Pharmaceuticals, Inc.

NASDAQ:ENTA

$293.92M

Foghorn Therapeutics Inc.

NASDAQ:FHTX

$243.08M

Orchestra BioMed Holdings, Inc.

NASDAQ:OBIO

$234.68M

Inventiva S.A.

NASDAQ:IVA

$184.28M

Humacyte, Inc.

NASDAQ:HUMA

$157.32M

Pyxis Oncology, Inc.

NASDAQ:PYXS

$127.03M

Tenaya Therapeutics, Inc.

NASDAQ:TNYA

$117.89M

Aardvark Therapeutics, Inc. Common Stock

NASDAQ:AARD

$86.07M

What is the latest CRBU filing?

The latest filing shown is 8-K dated Jun 11, 2026.

How many recent filings does CRBU have?

Intrinsic Alpha currently shows 20 recent filings for CRBU.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.